Jane Conley, MD
Allergy & Immunology · Knoxville, TNNPI 1407801608
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.2% of the total across 165 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,173, more than ten times the $109 reported in 2019. That places this record below the midpoint for allergy & immunology clinicians in TN, where the typical reported total is $6,300.
Across 165 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$584
- GSK$561
- Sanofi$461
- Regeneron Healthcare Solutions, Inc.$315
- AstraZeneca$304
- Sanofi-aventis U.S. LLC$193
- plus $898 from 14 others
What the payments were for
- Food & beverage$3,12294%
- Education$1936%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 22 | $584 |
| GSK | 48 | $561 |
| Sanofi | 21 | $461 |
| Regeneron Healthcare Solutions, Inc. | 13 | $315 |
| AstraZeneca | 15 | $304 |
| Sanofi-aventis U.S. LLC | 2 | $193 |
| Novartis | 7 | $151 |
| Kaleo, Inc. | 6 | $128 |
| Teva Pharmaceuticals USA, Inc. | 6 | $101 |
| Optinose US, Inc. | 4 | $90 |
| Grifols USA, LLC | 4 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $72 |
| CSL Behring | 2 | $48 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $47 |
| Octapharma USA, Inc. | 2 | $44 |
| Shire North American Group Inc | 2 | $42 |
| Cycle Pharmaceuticals Inc | 2 | $39 |
| Pfizer | 1 | $18 |
| Amgen | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
How this compares
$3,315 in reported general payments places this provider in the 35th percentile of 79 allergy & immunology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breo ElliptaFluticasone/Vilanterol | 27 | $11,657 |
| Qvar RedihalerBeclomethasone Dipropionate | 15 | $4,909 |
| Serevent DiskusSalmeterol Xinafoate | 12 | $4,833 |
| Arnuity ElliptaFluticasone Furoate | 12 | $4,276 |
| Epinephrine | 20 | $3,709 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 11 | $1,740 |
| Azelastine Hcl | 51 | $1,300 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 40 | $1,102 |
| Montelukast Sodium | 99 | $926 |
| Fluticasone Propionate | 66 | $693 |
| Ipratropium Bromide | 13 | $266 |
| Hydroxyzine Hcl | 20 | $221 |
| Famotidine | 23 | $111 |
| Prednisone | 18 | $60 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta, Arnuity Ellipta | $561 | $15,93239 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $101 | $4,90915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 79 allergy & immunology providers in Tennessee.
Other allergy & immunology in Knoxville
- Nicholas KolinskyKnoxville$472K
- Jeremiah BivinsKnoxville$10K
- Joseph EllenburgKnoxville$10K
- Jeffrey SchlactusKnoxville$9K
- Sangeetha KodothKnoxville$8K
- Michael SpringerKnoxville$7K
- Laura GreenKnoxville$7K
- Andrew SingerKnoxville$6K
- Donald EllenburgKnoxville$6K
- Jennifer HallKnoxville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.